The research group U746 CIBERER from the Madrid and led by Dr. Belén Pérez just published very promising results regarding a possible therapeutic strategy for PMM2-CDG. Dr. Bélen's team evaluated the effect of proteostasis regulators in the stability and activity of several variants of PMM2 and showed their potential to rescue the PMM2 defect.